Wednesday 6 May, 2009

Pregabalin (Lyrica) 25, 50, 75, 100, 150, 200, 225, 300 mg/capsule: Innovator Pfizer sues generic player

Pharma giant Pfizer has filed patent infringement suit against various generic players, who have filed ANDA with Para IV certification against Orange Book listed patents for neuropathic pain treatment Pregabalin (Lyrica) 25, 50, 75, 100, 150, 200, 225, 300 mg/capsule.

The lawsuit was filed on April 29, 2009 in Delaware District Court

Please read full article on following link:

http://genericpatentology.blogspot.com/2009/05/pregabalin-s-3-aminomethyl-5.html

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker